
Team PA helped facilitate meetings with the Governor's Action Team and officials from Endo Pharmeceuticals. The state announced Endo is staying and expanding its operations and will hire additional workers at its new facility in Southeastern PA.
Governor Tom Corbett visited the future site of Endo Pharmaceuticals’ corporate headquarters in Chester County, where he praised the company for its continued commitment to the region and its plans to create more than 150 high-paying jobs.
Team Pennsylvania Foundation provided support to the Governor’s Action Team (GAT) to make this project possible.
“Here in Pennsylvania we are employing the kind of creative cooperation that says yes to opportunity. And today we are cutting the ribbon on a new headquarters,” said Corbett. “This investment in the future means we have saved 475 existing jobs and will create another 154 positions over the next three years.”
“Team PA is proud to have played a major role in supporting GAT to not only ensure this company remained in the commonwealth, but is also able to add additional family-sustaining jobs as well,” said Team PA President & CEO Matt Zeiger.
Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments: branded pharmaceuticals, generics and devices and services. The company delivers a suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology.
During the visit, Gov. Corbett discussed his commitment to working with all Pennsylvania businesses to ensure future growth and job creation.
“The nation and this region are still climbing out of recession. To do so we have to keep our eye on the ball, and that ball is jobs,” said Corbett. “Endo and Trammell Crow are examples of what can happen when the state opens doors to business and jobs.”
Endo entered into a 10-year lease for approximately 315,000 square-feet of office space which will house their corporate headquarters. The company will retain their 475 existing employees and 100 contractors while also creating 154 new positions to be filled over the next 3 years.
“Today marks an important win for the people of Pennsylvania, and for Endo Pharmaceuticals,” said Corbett.





One Comment
Taxpayer’s take a pounding from political puffed shirts. Fact is Endo was looking at another location but was lured to a special government handout developed by a quarry which was also probably paid by the government. The owner of the property lured Endo to build using $65 million on a spot which civil engineers remarked does not have a strong base foundation. A five story building is going to be placed on the landfill inside a quarry! Two years tops before it starts to show signs of settling or sinking!! Then, the taxpayers will pay to shore it up! Fact is the government is shelling out political favors to already wealthy companies and not really helping other industries. It is true Endo will be hiring and creating jobs but they were going to do this already on their own dime!